The ubiquitin-proteasome system and the autophagy-lysosome pathway are the two main mechanisms for eukaryotic intracellular protein degradation. Proteasome inhibitors are used for the treatment of some types of cancer, whereas autophagy seems to have a dual role in tumor cell survival and death. However, the relationship between both pathways has not been extensively studied in tumor cells. We have investigated both proteolytic systems in the human epithelial breast non-tumor cell line MCF10A and in the human epithelial breast tumor cell line MCF7. In basal condition, tumor cells showed a lower proteasome function but a higher autophagy activity when compared with MCF10A cells. Importantly, proteasome inhibition (PI) leads to different responses in both cell types. Tumor cells showed a dose-dependent glycogen synthase kinase-3 (GSK-3)b inhibition, a huge increase in the expression of the transcription factor CHOP and an active processing of caspase-8. By contrast, MCF10A cells fully activated GSK-3b and showed a lower expression of both CHOP and processed caspase-8. These molecular differences were reflected in a dose-dependent autophagy activation and cell death in tumor cells, while non-tumor cells exhibited the formation of inclusion bodies and a decrease in the cell death rate. Importantly, the behavior of the MCF7 cells can be reproduced in MCF10A cells when GSK-3b and the proteasome were simultaneously inhibited. Under this situation, MCF10A cells strongly activated autophagy, showing minimal inclusion bodies, increased CHOP expression and cell death rate. These findings support GSK-3b signaling as a key mechanism in regulating autophagy activation or inclusion formation in human tumor or non-tumor breast cells, respectively, which may shed new light on breast cancer control.
degradation, 7 macroautophagy (hereinafter referred to as autophagy) is the most important form of autophagy. It involves the formation of a double-membrane vesicle, called autophagosome, initiated by elongation of a de novo-formed membrane that seals on itself, sequestering cargo inside. Finally, the double-membrane vesicle fuses with lysosomes leading to autophagolysosome formation, where the cargo is degraded. Selective degradation of proteins is thought to be an exclusive function of the UPS, but a growing body of evidence claims that participation of autophagy may also be relevant. The identification of proteins that target proteins for autophagy degradation, or mediate cargo of phagosomes, argues in favor of this idea. Destination of proteins for proteasome or autophagy degradation is regulated, at least in part, by the Bcl-2-associated athanogen (BAG) proteins. The expression of BAG1 and BAG3 acts as a molecular switch mechanism determining whether proteins are degraded by the proteasome or autophagy, respectively. 8, 9 In this sense, BAG3 was found to act in concert with the ubiquitin-binding protein p62/SQSTM1 to increase autophagic activity. Moreover, p62/SQSTM1 binds also to LC3II-and K63-ubiquitinated proteins, putting together all the elements necessary for the autophagy activation and targeted cargo proteins. Here we focused on both the proteolytic systems in a non-tumor and in a tumor cell line. We show that tumor cells are more dependent on autophagy. Indeed, proteasome inhibition (PI) in MCF10A cells induced the formation of inclusion bodies with minor cell death, while increased basal autophagy in MCF7 cells, avoiding the formation of inclusion bodies, but raising the cell death rate. We provide solid evidence supporting that glycogen synthase kinase-3 (GSK-3)b inhibition regulates autophagy activation induced by PI in the human breast cancer MCF7 cells.
Results
BAG1 and BAG3 are differentially expressed in MCF10A and MCF7 cells. As BAG-family proteins are involved in protein quality control, 10, 11, 8 we characterized the expression of BAG1 and BAG3 in MCF7 and MCF10A cells, respectively. Among the four BAG1 isoforms, 12 BAG1 (B36 kDa) and BAG1M (B46 kDa) were mostly detected in MCF10A cells, whereas in MCF7 cells predominated BAG1, in a very low extent, BAG1M and BAG1L (B50 kDa) ( Figure 1a ). On the other hand, basal expression of BAG3 was higher in MCF7 than in MCF10A cells, where it was practically absent (Po0.05; Figure 1a ). In consequence, the BAG3/BAG1 (B36 kDa) ratio was fourfold higher in tumor than in non-tumor cells.
Proteasome activity predominates in MCF10A and autophagy markers are increased in MCF7 cells. We further analyzed whether the different expression of BAG1 and BAG3 affected intracellular proteolytic systems. As shown in Figure 1b , MCF7 cells showed a significant reduction in the chymotrypsin-like activity of proteasome when compared with MCF10A cells (Po0.05). This activity is catalyzed by both the constitutive b5 and the inducible b5i/LMP7 subunits. 1, 13 Both the subunits were expressed in MCF10A cells, but only the constitutive b5 in MCF7 cells was detected ( Figure 1c ). The low expression of b5i/LMP7 was not restricted to this subunit, but also to the b1i/LMP2 (Figure 1c ). This could be consequence of the very low, if any, transcriptional expression of both subunits ( Figure 1d ). However, the structural subunit a2, present in both constitutive and immunoproteasome, was similarly expressed in both cell types, pointing to qualitative rather than quantitative differences in proteasomes between MCF7 and MCF10A cells. On the other hand, MCF7 cells showed a higher expression of several proteins related to the autophagy-lysosomal system. The autophagosome marker LC3II, in addition to proteins involved in the initiation of autophagy, such as Beclin-1 and Atg7, or the lysosomal enzyme cathepsin D, were more expressed in MCF7 than in MCF10A cells ( Figure 1e ). These data strongly indicate that intracellular proteolytic systems are altered in tumor MCF7 cells.
MCF7 are more vulnerable than MCF10A cells to cytotoxicity induced by acute PI. We next analyzed how PI affected cell survival. For that, proteasome activity was inhibited with MG132 for 24 h, and then cell viability was analyzed by sulforhodamine B (SRB) assay. Cell viability was similarly affected with lower dose tested in both cell lines (Figure 2a ). However, higher concentrations of MG132 significantly decreased the cell viability in MCF7 but not in MCF10A cells (Po0.05), indicating that MCF7 cells were more sensitive to PI. Then, we studied the expression of molecular markers corresponding to the extrinsic and intrinsic apoptotic pathways, in addition to markers of the unfolded protein response (UPR). Caspase-8 was highly processed in MCF7, but not in MCF10A cells (Figure 2b , upper panel and 2c). However, caspase-9 was not processed in any of both cell types (data not shown). By contrast, components of the UPR-PERK pathway such as the transcription factor activating transcription factor 4 (ATF4) was increased in both cell types, but the proapoptotic transcription factor CHOP, under control of ATF4, was strongly upregulated in MCF7, but weakly in MCF10A cells (Figure 2b , lower panel and 2d). Importantly, autophagy inhibition with 3-methyladenine mostly abolished CHOP expression ( Figure 3a ), supporting that CHOP induction is more dependent on autophagy activation than on PI. Moreover, cell death induced by PI was almost abolished in Atg5 small interfering RNA (siRNA) MCF7 cells when compared with control siRNA MCF7 cells (Figure 3b ), supporting that autophagy is a potential mechanism underlying cell death induced by PI in MCF7 cells.
PI induces autophagy activation in MCF7 but formation of inclusion bodies in MCF10A cells. We further investigated the cellular response induced by PI by performing a molecular analysis in both cell types. On the basis of previous data, we used 1 mM and 5 mM of MG132. We focused on the expression of BAG1 and BAG3 proteins. Regarding BAG1, we only analyzed the BAG1 isoform (B36 kDa) because it was the most abundantly expressed in both cell types. In MCF10A, BAG1 expression decreased following PI (Po0.05), whereas in MCF7 cells it remained similar to the control condition (Figures 4a and b Thus, we speculate that MCF7 cells are more dependent on autophagy activity, whereas MCF10A cells are more dependent on proteasome degradation and need a stronger PI to activate autophagy. To prove directly this supposition, we performed an ultrastructural analysis using transmission electron microscopy (TEM). In control condition, we did not observe any relevant differences between both cell types (Figures 5Da and d) . However, the morphological features induced by PI were completely different. On one hand, MCF10A cells accumulated electron-dense structures around the nucleus that increased in number and size in a dose-dependent manner (Figure 5Db ). These aggregatedlike structures were membrane-free and were surrounded by numerous mitochondria (Figure 5Dc ). The presence of multilamellar structures resembling autophagolysosomes was never observed in these cells. On the other hand, tumor cells MCF7 displayed a significant cytoplasmic vacuolization that increased also in a dose-dependent manner (Figure 5De ). These cytoplasmic structures were different in size and showed a heterogeneous content that corresponded to digestion products ( Figure 5Df ). Importantly, the presence of inclusion bodies was never observed in MCF7 cells. To test whether these cytosolic vacuoles could correspond to autophagolysosomes, we used acridine orange for acidic vesicle organelles detection. 15 As shown in Supplementary Figure 1A , the number of acidic vesicles labeled with acridine orange increased in a dose-dependent manner in MCF7 but not in MCF10A cells, indicating a higher biogenesis of lysosomes and/or autophagolysosomes induced by PI in tumor cells. Moreover, to determine whether the accumulation of LC3II induced by PI in MCF7 cells is caused by stimulation of autophagy or inhibition of autophagic vesicle turnover, we performed both morphological and biochemical analysis. Ultrastructural analysis performed following PI (MG132 1 mM) revealed the presence of features of autophagy activation such as abundant lysosomes, concentric double-membrane structures and cytosolic vacuoles containing digestion products (Supplementary Figure 1B ). Moreover, PI in MCF7 cells in the absence or presence of chloroquine 5 mM showed a higher LC3II accumulation in the presence of chloroquine, supporting autophagy flux (Supplementary Figure 1C) . These results indicate that restoration of cellular homeostasis occurred in two different ways in both cell types: MCF7 overactivated basal autophagy, whereas MCF10A induced the formation of inclusion bodies.
PI promotes the accumulation of K63-ubiquitinated proteins, preferentially in MCF10A. Cellular inclusions are enriched in K63-ubiquitinated proteins. [16] [17] [18] Thus, we investigated the topology of ubiquitin linkages in MCF10A and MCF7 cells. First, we quantified total poly-ubiquitinated proteins accumulated, following PI. As shown in Figures 6a and b, the accumulation of poly-ubiquitinated proteins was higher in MCF10A than in MCF7 cells. Interestingly, the linkage ubiquitin topology was little different in both the cell types. In MCF10A, PI preferentially accumulated (Figure 6c ). In consequence, the K63/K48 ratio augmented in a dosedependent manner in MCF10A, but remained quite similar in MCF7 cells (Figure 6d ). Importantly, ubiquitination profile was somehow regulated by BAG1 and BAG3 proteins. Indeed, PI in MCF10A cells transfected with BAG1 or BAG3 siRNAs slightly increased or severely decreased the content of K63-ubiquitinated proteins, respectively (Figure 6e ). Thus, PI promotes the formation of protein inclusions enriched in K63-ubiquitinated proteins in MCF10A cells, whereas in MCF7 induces autophagic activity avoiding the formation of those inclusions.
GSK-3b is inhibited in MCF7 but fully activated in MCF10A cells, following PI. We next tried to identify additional pathways that could account for the different response induced by PI in both cell types. As GSK-3b inactivation has been demonstrated to participate in autophagy activation and cell death under stress situation, 19 we focused our attention on the Akt/GSK-3 pathway. As shown in Figure 7a , PI increased in a dose-dependent manner GSK-3b phosphorylation on Ser9 in MCF7, but not in MCF10A cells. Thus, GSK-3b was specifically inactivated in the tumor cells but remained active in MCF10A cells. To test whether this was related to the tumorigenic origin of cells, we used a transformed isogenic cell line of the MCF10A cells, named MCF10A-NeuT, which constitutively expresses an active form of the oncogene ErbB2/HER-2/NeuT. 20 PI produced both a higher GSK-3b phosphorylation on Ser9 and accumulation of LC3II in MCF10A-NeuT cells. This behavior was similar to that observed in MCF7 cells (Supplementary Figure 1D ), indicating that differential regulation of GSK-3b by PI seems to be related with the tumorigenic origin of these cells. Moreover, MCF10A but not MCF7 cells augmented phosphorylation of GSK-3b on Tyr216, leading to a higher (Figure 7a , middle). The lower activity of GSK-3b was reflected in the accumulation of b-catenin, exclusively in MCF7 cells (Figure 7a , lower part). Interestingly, the behavior of GSK-3a was also opposed in both cell types after PI (Figure 7a ). Next, we analyzed both Akt and protein kinase C (PKC)d phosphorylation, two kinases that phosphorylate GSK-3b on Ser9. 21 PI increased phosphorylation of Akt on Ser473 in both cell types, being the ratio of P-Akt/Akt higher in MCF10A than in MCF7 cells using MG132 5 mM (Figure 7b upper panel Po0.05). By contrast, the phosphorylation on Thr308 was exclusively detected in MCF7 cells in both, basal condition and following PI (Figure 7b lower panel) . Similarly, PI induced phosphorylation of PKCd in MCF7 but not in MCF10A cells (Figure 7c ). These data indicate that PI induces an inverse regulation of signaling pathways involving GSK-3b in both cell lines.
Autophagy activation induced by PI is dependent on GSK-3b inactivation in MCF10A cells. To investigate whether GSK-3b inhibition and autophagy activation were causally related, we inhibited GSK-3b activity using lithium chloride (LiCl) and induced PI in MCF10A cells, which neither activated autophagy nor inhibited GSK-3b. As shown in Figure 8a , treatment with LiCl sensitized MCF10A cells to PI (MG132 1 mM; see Figure 5 ). As expected, LiCl (30 mM) increased Ser9 phosphorylation in GSK-3b. Furthermore, the level of LC3II was slightly higher because of the transcriptional activation of the LC3 gene (data not shown). A similar effect was obtained using the specific GSK-3b inhibitor VII (Supplementary Figure 1E) . Moreover, LiCl augmented the phosphyorylation of PKCd (Figure 8a ), but not Akt phosphorylation (data not shown). Under this situation, PI strongly increased either the level of LC3II, the phosporylation of PKCd as well as CHOP expression. Cotreatment with LiCl and MG132 induced morphological changes in the cytoplasm of MCF10A cells, which were different to that observed in cells treated with MG132 alone. As previously shown, PI induced the formation of inclusion bodies without the evidence of autophagy activation (Figure 8b) . However, the combination of LiCl and MG132 produced a high cytoplasmic vacuolization with minimal cytosolic aggregation (Figure 8b ). Electron microscopy revealed the presence of inclusion bodies in MCF10A cells treated with MG132, but cytosolic vacuoles in cotreated MCF10A cells (Figure 8b lower panel) . Some of these vacuoles were observed surrounding cytosolic aggregates (magnification in Figure 8b) , showing heterogeneous content that may correspond to digestion products. These data strongly support that GSK-3b inhibition is necessary for autophagy activation. As autophagy inhibition decreased cell death induced by PI in MCF7 cells (Figure 3b ), we investigated whether autophagy activation could increase cell death in MCF10A. As shown in Figure 8c , PI in the presence of LiCl significantly increased cell death compared with PI alone.
Discussion
We have characterized the two major cellular pathways involved in protein degradation in MCF10A and MCF7 cells.
The study was carried out in both, basal and proteasome stress situations. In basal condition, MCF7 cells showed a lower proteasome activity that could be due, at least in part, to the absence of immunoproteasomes. The downregulation of immunoproteasome could benefit cancer cells by inhibiting antigen presentation, which in turn, could constitute an immune evasion strategy for some tumor types. The absence or reduced expression of immunoproteasomes has been previously described in other tumor cell lines. [22] [23] [24] [25] [26] Thus, our results support the idea that immunoproteasome represents a promising prospect for certain tumors including breast cancer. The lowering of proteasome activity seems to be compensated by a higher autophagy activity. A growing body of evidence suggests that basal autophagy has a relevant homeostatic role in maintaining protein and organelle quality control, acting in parallel with the UPS to prevent accumulation of poly-ubiquitinated and aggregated proteins. 7, 27 Therefore, our results are in line with this idea. Although molecular links between both proteolytic systems are not completely understood, BAG1 and BAG3 have an important role in regulating both processes. 28, 8, 9, 11 BAG3 was overexpressed in MCF7 cells in basal condition, whereas its expression was residual in MCF10A cells. Importantly, differences in the proteolytic systems in basal condition determined the response to PI in both cell types. On one hand, cell mortality was higher in tumor cells than in non-tumor cells, and on the other hand the homeostatic response was completely different in both cell types. Biochemical data demonstrated that MCF7 cells did not modify the expression of BAG1 and coordinately upregulated, in a dose-dependent manner, the expression of BAG3, p62/SQSTM1 and LC3II. By contrast, MCF10A cells downregulated the expression of BAG1, but also upregulated BAG3, p62/SQSTM1 and LC3II, although with different dynamics and sensitivity to PI. These molecular differences were also reflected at the cellular level. Ultrastuctural analysis revealed that MCF7 cells showed profuse autophagy activation with none or minimal cytosolic inclusions, whereas MCF10A cells presented aggresome-like structures, without evidence of autophagy activation. Sequestration of aggregated proteins is classically considered a cellular response that occurs once the refolding capacity and degradation of soluble misfolded proteins are overpassed. 29 Thus, our results indicated that tumor cells are more dependent on the autophagy, whereas non-tumor cells seem to be more dependent on the proteasome. Sequestration of misfolded proteins in MCF10A cells has a protective role in this context. Autophagy is considered a non-selective degradative system, but growing evidence support the existence of selective autophagy that specifically targets protein aggregates for their clearance. 30 In this sense, the ubiquitination pattern of proteins targeted for degradation could determine whether adapter proteins will bring them to the autophagosomes or to the proteasome. 31, 32, 18 We demonstrated that dynamics of ubiquitinated proteins induced by PI was somehow different in both cell types. The K63/K48 ratio increased in a dose-dependent manner in MCF10A but not in MCF7 cells. Ubiquitination on K48 is considered a signal for proteasome degradation, whereas ubiquitination on K63 preferentially destines proteins to the autophagy-lysosomal pathway. 3, 31 However, it has also been described that K63-ubiquitinated proteins are more prone to form intracellular inclusions. 17, 18 On the other hand, the role of p62/SQSTM1 in the biogenesis of intracellular protein aggregates is well documented. This stress-regulated multiadaptor protein binds to both aggregated poly-ubiquitinated proteins, preferentially on K63 and LC3. 33, 14, 16, 31, 34 Moreover, it is well established that p62/SQSTM1 regulates inclusion body formation and degradation by autophagy. 35, 36 Thus, we speculate that electron-dense structures induced by PI in MCF10A cells might agglutinate K63-ubiquitinated proteins, in addition to p62/SQSTM1, BAG3 and LC3. However, we cannot discard that other proteins showing different patterns of ubiquitination, or even non-ubiquitinated proteins, might take part in these intracellular inclusions. A similar situation could be operating in the tumor cells MCF7. However, because of the faster autophagy activation, probably due to the higher basal activity, protein accumulation and autophagy overactivation are better synchronized, avoiding protein accumulation. At this point, a relevant question is to know the molecular mechanisms underlying the different homeostatic responses in both cell types. We show strong evidence indicating that it somehow depends on GSK-3b activity. Indeed, GSK-3b was inversely regulated in both cell types following PI (inhibited in a dose-dependent manner in tumor cells and fully activated in non-tumor cells). Moreover, dose-dependent inactivation of GSK-3b was paralleled by dose-dependent activation of autophagy in MCF7 cells, and most importantly, autophagy activation in MCF10A cells only occurred when proteasome and GSK-3b were simultaneously inhibited. Under this situation, most of the molecular and morphological features induced by PI in MCF7 cells were reproduced in cotreated MCF10A cells such as, accumulation of LC3II, increased PKCd phosphorylation, higher CHOP expression, extensive vacuolization with minor inclusion bodies and higher cell death. Thus, our results are in line with the recent data indicating that GSK-3b has a relevant role in regulating autophagy activity in tumor cells under stress situations. 19, 37 Under ER-stress, cells activate a signaling pathway called UPR that is mediated by the sensor proteins PERK, IRE1a and ATF6, in order to mitigate the cellular stress. 38 The UPR and autophagy activation are two linked phenomena. 39, 40 In particular, PERK pathway mediates transcriptional activation of LC3, Atg5 and Atg12 genes by the transcription factors ATF4 and CHOP. [41] [42] [43] In this sense, we observed strong upregulation of ATF4 and mostly CHOP in MCF7, but not in MCF10A cells, following PI. However, in MCF10A subjected to both GSK-3b and PI, CHOP expression increased even more, similarly as observed in MCF7 cells. Finally, caspase-8 has also been linked to autophagy activation [44] [45] [46] [47] and autophagy activity is necessary for GSK-3b inhibition and autophagy activation in tumor cells E Gavilán et al cleavage of caspase-8 induced by PI. 48, 19 Thus, the higher processing of caspase-8 in MCF7 cells in both, basal-and proteasome stress situations might represent an additional factor that contributes to the higher basal autophagy activity in the tumor cell line MCF7. Collectively, our findings strongly argue for the induction of autophagy as the main way to restore cell homeostasis under proteasome stress situation in the human breast cancer cells, MCF7. Moreover, we provide solid evidence supporting that efficient autophagy activation in response to PI is dependent on GSK-3b. This finding is in line with a recent work, demonstrating that GSK-3b inhibition promoted lysosomal biogenesis and autophagy protein degradation. 49 Finally, we also show that autophagy has an active role on cell death in the tumor cell line MCF7 subjected to proteasome stress. However, we cannot discard the possibility that autophagy activation in response to PI might be initially a prosurvival process in an attempt to keep cells alive, but with fatal collateral consequences.
Materials and Methods
Cells and culture conditions. The study was carried out in an ER þ human epithelial breast cancer cell line, MCF7 and in a human epithelial-non tumorigenic breast cell line, MCF10A (American Type Culture Collection). MCF7 cells were cultured in DMEM/Ham's F12 (1/1) medium (PAA Laboratories, Piscataway, NJ, USA) supplemented with 10% (v/v) fetal bovine serum (FBS; Gibco, Alcobendas, Spain), 2 mM L-glutamine, 50 mg/ml streptomycin and 50 U/ml penicillin (Sigma-Aldrich, Madrid, Spain). The human mammary epithelial cells MCF10A and the transformed cell lines MCF10A-NeuT (oncogen ErbB2/HER-2/NeuT constitutively expressed) and MCF10A-pBabe (empty plasmid) were grown in DMEM/Ham's F12 (1/1) medium (PAA Laboratories) supplemented with 10% (v/v) horse serum (Gibco), 2 mM L-glutamine, 50 mg/ml streptomycin, 50 U/ml penicillin, 2.5 mg/ml insulin, 150 mg/ml cholera enterotoxin (Sigma-Aldrich), 2.5 mg/ml hydrocortisone and 50 mg/ml epidermal growth factor (Calbiochem, Billerica, MA, USA). Both cell lines were maintained at 37 1C in a humidified atmosphere with 5% CO 2 . Cells were routinely subcultured and they were always in exponential growth phase when used for experiments. Each experiment was independently performed at least in triplicate.
Treatments and drugs. Both cell lines were treated in parallel with the reversible proteasome inhibitor MG132 (Sigma-Aldrich), at doses indicated in the figures during 24 h. Cells were also treated with 30 mM of LiCl for 24 h (Sigma-Aldrich) or 20 mM of GSK-3b inhibitor VII (Calbiochem) for GSK-3b inhibition. Treatments were carried out alone or in combination.
Proteasome activity assay. Chymotrypsin-like activity was determined using 50 mM of Suc-Leu-Leu-Val-Tyr-aminomethylcoumarin (AMC; Sigma-Aldrich) as substrate, as previously described. 50 Assay mixtures containing 10 mg of protein, substrate and 50 mM HEPES-KOH, pH 7.5, was made up in a final volume of 100 ml. Measures were performed at 37 1C, by monitoring fluorescence emission (excitation wavelength 380 nm, emission wavelength 460 nm) on a Thermo Scientific Varioskan Flash Spectral Scanning Multimode Reader (software Scanlt, version 2.4.1, Alcobendas, Spain). The fluorescence emission was first determined 2 min after substrate incubation and then every 15 min during a total incubation period of 75 min. The product formation was linear during this time. Triplicate assays were performed for MCF10A and MCF7 cells, and determinations were always performed in parallel. Activity was calculated by comparing the slopes of the line obtained by plotting fluorescence versus the time of incubation. Background activity was determined by addition of the proteasome inhibitor MG132 (Sigma-Aldrich), at a final concentration of 10 mM.
Sulforhodamine B assay. To assay cell viability, cells in exponential growth phase were harvested using trypsin-EDTA (Gibco), and resuspended in their respective media. Cells were seeded at a density of 5 Â 10 3 cells/100 ml in a 96-well microtiter plate (Nunc, Roskilde, Denmark) and then allowed for 24 h to attach and grow. Then, they were incubated further for 24 h in the presence of proteasome inhibitor MG132. The concentration range tested (200 nM-50 mM) was prepared in a culture medium from a stock solution in DMSO (Sigma-Aldrich). Following the recommendations of the National Cancer Institute (Bethesda, MD, USA), the analysis of cytotoxic effects induced by MG132 was determined using a cell growth assay, the SRB (Sigma-Aldrich) assay, as previously described. 51, 52 Briefly, 50 ml per well of cold 50% trichloroacetic acid (TCA; final concentration 10%) was added to the culture and incubated at 4 1C for 1 h, to precipitate the proteins and fix the cells. The supernatant was then discarded, and the plates were washed five times with distilled water and air-dried. The cells were then stained with 100 ml per well of 0.4% SRB dissolved in 1% acetic acid for 30 min at room temperature. Unbound SRB was removed by washing five times with 1% acetic acid, and then plates were air-dried. The stained protein was solubilized in 100 ml per well of 10 mM Tris Base, pH ¼ 8.7 by shaking. The optical density was read at 515 nm using a microtiter plate reader (ELISA).
Acridine orange staining. As a marker of autophagy the cellular acidic compartments can be visualized by acridine orange staining. Cells were seeded on coverslips in the absence or in the presence of MG132 (1 or 5 mM, for 24 h). Then cells were washed with PBS and incubated for 10 min with medium containing 0.1 mg/ml acridine orange (Molecular Probes, Alcobendas, Spain). The acridine orange was removed by washing coverslips with PBS (for 5 min three times). Fluorescent images were taken using a fluorescent microscope (Olympus BX61, Barcelona, Spain).
Western blotting. Immunoblots were done as previously described. 50 Briefly, proteins were loaded on a 12 or 14% polyacrylamide gel for electrophoresis (SDS-PAGE; Bio-Rad, Alcobendas, Spain) and then transferred to a nitrocellulose membrane (Hybond-C Extra; Amersham, Barcelona, Spain). After blocking, membranes were incubated overnight at 4 1C, with the following primary antibodies: (i) rabbit polyclonal antibodies against: Akt, phospho-Akt(S473), phospho-Akt(T308), Atg5, Atg7, Beclin-1, Caspase-9, Cleaved Caspase-8, LC3B, phospho-GSK-3b(S9) and SQSTM1/p62 (Cell Signaling, Danvers, MA, USA); BAG1 (c-16), Proteasome 20S alpha2 subunit (H-120; Santa Cruz Biotech, Heidelberg, Germany). P-GSK-3a(Y279)/b(Y216; Invitrogen, Alcobendas, Spain); Ubiquitin (Dako, Glostrup, Denmark); Proteasome 20S alpha þ beta, Proteasome 20S b5i/LMP7 and Proteasome 20S b1i/LMP2 (Abcam, Cambridge, UK); K48linkage Specific poly-ubiquitin Antibody (Cell Signaling) and K63-linkage Specific poly-ubiquitin (D7A11; Cell Signaling); (ii) mouse monoclonal antibodies against: b-actin (Sigma-Aldrich); CHOP (Cell Signaling); GSK 3-clone 4G-1E (Millipore, Madrid, Spain); ATF4 (Abcam) and (iii) goat polyclonal antibody against BAG3 (P-17) (Santa Cruz Biotech). Then, membranes were incubated with the appropriate secondary antibody (Dako) horseradish peroxidase-conjugated, at a dilution of 1/ 10000 and developed using the ECL-plus detection method (Amersham) and the ImageQuant LAS 4000 MINI GOLD (GE Healthcare Life Sciences, Barcelona, Spain). For quantification, the optical density of individual bands was analyzed using PCBAS 2.08 software (Raytest Inc, Berlin, Germany), and the optical density of each band was normalized relative to the optical density of b-actin.
RNA extraction and reverse transcription. For PCR analysis, total RNA was extracted using the Tripure Isolation Reagent (Roche, Mannheim, Germany), according to the instructions of the manufacturer. The recovery of RNA was similar between MCF10A and MCF7 cells. Reverse transcription was performed using random hexamers primers exactly as previously described. 53 Real-time reverse transcriptase-PCR. cDNAs were diluted in sterile water and used as template for the amplification by the PCR. Optimization and amplification of each specific gene product was performed using the ABI Prism 7000 sequence detector (Applied Biosystems, Barcelona, Spain) and TaqMan probes designed by Applied Biosystems, as previously described. 50 The cDNA levels of the different cell types were determined using two different housekeepers (glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and b-actin). The amplification of the housekeepers was done in parallel with the gene to be analyzed. Similar results were obtained using both housekeepers. Thus, the results were normalized using both b-actin and GAPDH expression. Threshold cycle (Ct) values were calculated using the software supplied by Applied Biosystems.
Small interfering RNA. MCF10A and MCF7 cells were transfected during 48 h with 100 nM of siRNA using Dharma-FECT 1 siRNA transfection reagent GSK-3b inhibition and autophagy activation in tumor cells E Gavilán et al (Dharmacon, Madrid, Spain). MCF10A cells were transfected with BAG1 siRNA FlexiTube GeneSolution (GS573) or BAG3 siRNA FlexiTube GeneSolution (GS9531). MCF7 cells were transfected with Atg5 siRNA FlexiTube GeneSolution (GS9474). Control cells were transfected with AllStars Negative Control siRNA. All siRNA were purchased from Qiagen, Las Matas, Spain.
Transmission electron microscopy. Cell monolayers were fixed in 2.5% (v/v) glutaraldehyde in 0.1 M sodium cacodylate-HCl buffer pH ¼ 7.4 for 1 h at 4 1C. Cells were rinsed in cacodylate buffer twice and incubated for 1 h at 41C in 1% (v/v) OsO 4 /1% (w/v) K 4 Fe(CN) 6 in cacodylate buffer pH ¼ 7.4. Cells were rinsed again in cacodylate buffer and finally in distilled water. Then, cells were stained with 1% (w/v) aqueous uranyl acetate for 2 h at 4 1C. After washing with distilled water, they were dehydrated through increased graded ethanol series and embedded in Epon resin 812 (Sigma-Aldrich, Tres Cantos, Spain). Ultrathin sections were stained with lead citrate for 5 min. Toluidine blue-stained 0.5 mm semithin sections were used as control. All reagents were purchased from Sigma-Aldrich.
Statistical analysis. Data were expressed as mean±S.D. All our data fit significantly to a normal distribution according to a standardized Kurtosis test. The differences between groups were measured using a one-way ANOVA, followed by Tukey test. The significance was set at 95% confidence intervals. Significant differences are referenced as Po0.05 in the text. Statistical analysis was done using the statgraphics plus (v 3.1) program, Warrenton, VA, USA.
